Dr. Constantine Farmakidis, MD
- Medicare services, 2024
- 516
- Medicare patients, 2024
- 271
- Part D claims, 2024
- 1,239
- Publications
- 15
- Clinical trials
- 1
- Practice address
- 4000 Cambridge Street, Kansas City, KS 66160
- Practice phone
- Call (913) 588-5000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Farmakidis' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Constantine Farmakidis is a neurologist in Kansas City, Kansas
Dr. Farmakidis practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.
Dr. Farmakidis' NPI, 1508970948, was assigned on August 19, 2006. Dr. Farmakidis graduated from University of Rochester School of Medicine and Dentistry in 2006. Dr. Farmakidis holds Kansas license 04-40317.
- NPI
- 1508970948NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1355519786
- NPI enumeration date
- August 19, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (913) 588-5000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 46
- Medical school graduation
- 2006
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Constantine Farmakidis practices at The University of Kansas Hospital in Kansas City, Kansas
Dr. Farmakidis' primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.
- The University of Kansas Hospital4000 Cambridge Street, Kansas City, KS 66160 · Wyandotte CountyPhone(913) 588-5000
Source: Dmand AI Affiliation Data
Dr. Constantine Farmakidis is affiliated with 2 sites of care and 1 medical group
Dr. Farmakidis' primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Farmakidis to 1 more group practice or clinic, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Constantine Farmakidis' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farmakidis practices, 2 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| The University of Kansas Hospital | Available with a free account |
| +1 more affiliated site | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across The University of Kansas Health System and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Constantine Farmakidis is one of 131 neurologists in Kansas
Neurology is Dr. Farmakidis' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Farmakidis is licensed in Kansas.
Specialties and state licenses
- Neurology, KansasPrimary
Neurologists near Dr. Farmakidis
Counts of neurologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Constantine Farmakidis billed Medicare for 516 services in 2024
CMS data shows 516 Medicare services from Dr. Farmakidis across 8 procedure codes in 2024, for 271 Medicare patients. Medicare paid $31,844 for them. Every service was in an office.
Dr. Farmakidis' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3432024: 30112%
- Tests and treatments
- 2023: 1692024: 1605%
- Other services
- 2023: 02024: 55
Dr. Farmakidis compared with the Kansas median for neurologists, 2024
- Dr. Farmakidis
- Kansas median
- Medicare services
- 516vs 494Close to median
- Medicare patients
- 271vs 281Close to median
- Part D claims
- 1,072vs 75841% above
Medians across 126 neurologists in Kansas with Dmand AI profiles that report each measure.
Dr. Farmakidis' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Farmakidis?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Farmakidis and other neurologists in Kansas.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Constantine Farmakidis treated 271 Medicare patients in 2024, average age 71
CMS counts 271 Medicare patients who saw Dr. Farmakidis in 2024. The largest group is 65 to 74, with 113 patients. 73% of them have high cholesterol, and 71% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Farmakidis' median patient age at 69, with 53% women.
Dr. Farmakidis' Medicare patients by age, 2024
Dr. Farmakidis' Medicare patients by sex, 2024
- Women11844%
- Men15356%
Chronic conditions among Dr. Farmakidis' Medicare patients, 2024
- High cholesterol73%
- High blood pressure71%
- Arthritis54%
- Ischemic heart disease38%
- Diabetes35%
- Mood disorders35%
- Depression32%
- Anxiety29%
Share of Medicare patients with each condition. A patient can have several.
Dr. Farmakidis' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 69
Patient panel by sex, all payers
- Women53%
- Men47%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Constantine Farmakidis wrote 1,239 Medicare Part D claims in 2024
In 2024, Dr. Farmakidis wrote 1,239 Medicare Part D claims for 202 patients. 86% of them were for generic drugs. CMS names the drug for 1,072 of them, across 22 drugs with 11 or more claims each, at $3,616,624 in total drug cost. In 2023, CMS named 797 claims across 18 drugs.
Dr. Farmakidis' Part D claims by kind of drug, 2024
- Generic1,060 claims86%
- Brand-name and other179 claims14%
Dr. Farmakidis' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 7972024: 1,07235%
Drugs named by CMS: 22 in 2024, 18 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Constantine Farmakidis scored 93 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Farmakidis for performance year 2024, reported through an alternative payment model (APM). Dr. Farmakidis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Farmakidis as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Farmakidis' MIPS scores, performance year 2024
- 93of 100Final score
- 77of 100Quality
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Constantine Farmakidis has 15 publications on record
Dmand AI links 15 papers to Dr. Farmakidis, published from 2013 to 2024. 2015 was the busiest year, with 3. Dr. Farmakidis has published most often in Muscle Nerve. Dr. Farmakidis' most frequent co-authors are Mamatha Pasnoor, MD, Mazen M. Dimachkie, MD and Richard J. Barohn, MD.
Dr. Farmakidis' papers by year, 2013 to 2024
Dr. Farmakidis' most frequent co-authors
- Mamatha Pasnoor, MD7 shared papers
- Mazen M. Dimachkie, MD4 shared papers
- Richard J. Barohn, MD3 shared papers
Recent publications by Dr. Farmakidis
Muscle Nerve
Curr Treat Options Neurol
See who Dr. Farmakidis researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Farmakidis works with, so you can find a warm path to the right neurologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Constantine Farmakidis has worked on 1 clinical trial
Dmand AI links Dr. Farmakidis to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Amyotrophic Lateral Sclerosis and TDP-43 Proteinopathies.
Conditions in Dr. Farmakidis' trials
- Amyotrophic Lateral Sclerosis
- TDP-43 Proteinopathies
Investigators on the most trials with Dr. Farmakidis
- Benjamin Barnes, MD1 shared trial
- Deborah Y. Bradshaw, MD1 shared trial
- Adam Daniel Comer, MD1 shared trial
Recent clinical trials with Dr. Farmakidis
Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Constantine Farmakidis received $22,634 in industry payments from 2022 to 2025
CMS Open Payments shows 27 general payments to Dr. Farmakidis from 4 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 88% of the total. UCB, Inc. paid the most, $13,091.
General payments to Dr. Farmakidis by program year, 2022 to 2025
General payments to Dr. Farmakidis by kind, 2022 to 2025
- Consulting fees$19,93088%
- Travel and lodging$2,28610%
- Food and beverage$4192%
Companies that paid Dr. Farmakidis the most, 2022 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Constantine Farmakidis graduated from University of Rochester School of Medicine and Dentistry
Dr. Farmakidis graduated from University of Rochester School of Medicine and Dentistry in 2006.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Constantine Farmakidis's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Constantine Farmakidis
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Constantine Farmakidis' NPI number?
Dr. Constantine Farmakidis' NPI number is 1508970948. It was assigned on August 19, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Constantine Farmakidis?
Dr. Constantine Farmakidis is a neurologist in Kansas City, Kansas. The primary specialty in the NPI Registry is Neurology Physician (taxonomy code 2084N0400X).
Where does Dr. Constantine Farmakidis practice?
Dr. Farmakidis practices at 4000 Cambridge Street, Kansas City, KS 66160. Dr. Farmakidis' primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dmand AI also links Dr. Farmakidis to 1 group practice or clinic.
What is Dr. Constantine Farmakidis' office phone number?
The practice phone on file for Dr. Farmakidis is (913) 588-5000.
What is Dr. Constantine Farmakidis' medical license number?
Dr. Farmakidis holds Kansas license 04-40317.
Which hospitals is Dr. Constantine Farmakidis affiliated with?
Dr. Farmakidis practices at The University of Kansas Hospital in Kansas City, Kansas.
What medical group is Dr. Constantine Farmakidis part of?
Dr. Farmakidis is linked to Kansas University Physicians.
Does Dr. Constantine Farmakidis accept Medicare?
Yes. CMS data shows Dr. Farmakidis billed Medicare for 516 services in 2024, and Dr. Farmakidis accepts Medicare assignment.
Does Dr. Constantine Farmakidis offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Farmakidis as offering telehealth services.
What is Dr. Constantine Farmakidis' MIPS score?
Dr. Farmakidis' MIPS final score for performance year 2024 is 93 out of 100, reported through an alternative payment model (APM).
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Constantine Farmakidis see?
CMS counts 271 Medicare patients who saw Dr. Farmakidis in 2024, with an average age of 71.
What services does Dr. Constantine Farmakidis bill to Medicare?
In 2024, Dr. Farmakidis' most billed Medicare services were office visit, established patient (99214), nerve and brain test (95885) and office visit, established patient (99215).
Where did Dr. Constantine Farmakidis go to medical school?
Dr. Farmakidis graduated from University of Rochester School of Medicine and Dentistry in 2006.
What drugs does Dr. Constantine Farmakidis prescribe most?
In 2024 Medicare Part D data, Dr. Farmakidis' most prescribed drugs by claims were Gabapentin, Prednisone and Pyridostigmine Bromide.
Has Dr. Constantine Farmakidis received payments from drug or device companies?
CMS Open Payments shows $22,634 in general payments to Dr. Farmakidis from 4 companies from 2022 to 2025. The largest total came from UCB, Inc.
How long has Dr. Constantine Farmakidis been practicing?
Dr. Farmakidis graduated from medical school in 2006, 20 years ago.
Does Dr. Constantine Farmakidis do research?
Dmand AI links 15 publications to Dr. Farmakidis, published from 2013 to 2024. Dr. Farmakidis has worked on 1 clinical trial.
Who does Dr. Constantine Farmakidis publish with?
Dr. Farmakidis' most frequent co-authors are Mamatha Pasnoor, MD (7 shared papers), Mazen M. Dimachkie, MD (4 shared papers) and Richard J. Barohn, MD (3 shared papers).
Selling to neurology practices?
See neurologists in Kansas by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card